Inherent risks associated with manufacture of bioengineered ocular surface tissue.
about
A serum- and feeder-free technique of culturing human corneal epithelial stem cells on amniotic membrane.Serum-free and xenobiotic-free preservation of cultured human limbal epithelial cells.Xenobiotic- and Serum-Free Culture of Oral Mucosal Epithelial Cells on Contact Lenses.Cellular response of limbal epithelial cells on electrospun poly-ε-caprolactone nanofibrous scaffolds for ocular surface bioengineering: a preliminary in vitro study.The Silk-protein Sericin Induces Rapid Melanization of Cultured Primary Human Retinal Pigment Epithelial Cells by Activating the NF-κB Pathway.An important role for adenine, cholera toxin, hydrocortisone and triiodothyronine in the proliferation, self-renewal and differentiation of limbal stem cells in vitro.Optimal isolation and xeno-free culture conditions for limbal stem cell function.13 years of cultured limbal epithelial cell therapy: a review of the outcomes.Current status and future prospects for cultured limbal tissue transplants in Australia and New Zealand.Corneal surface reconstruction - a short review.The potential of nanofibers in tissue engineering and stem cell therapy.Natural killer cells as a promising tool to tackle cancer-A review of sources, methodologies, and potentials.Advances in corneal cell therapy.Clinical transplantation of ex vivo expanded autologous limbal epithelial cells using a culture medium with human serum as single supplement: a retrospective case series.Safety of Cultivated Limbal Epithelial Stem Cell Transplantation for Human Corneal Regeneration.Optimization of Corneal Epithelial Progenitor Cell Growth on Bombyx mori Silk Fibroin Membranes.Limbal stromal cells derived from porcine tissue demonstrate mesenchymal characteristics in vitroComparison of upstream regulators in human ex vivo cultured cornea limbal epithelial stem cells and differentiated corneal epithelial cells.Plasma polymer-coated contact lenses for the culture and transfer of corneal epithelial cells in the treatment of limbal stem cell deficiencyUnrestricted Somatic Stem Cells, as a Novel Feeder Layer: Ex Vivo Culture of Human Limbal Stem Cells.Treatment of ocular surface injuries by limbal and mesenchymal stem cells growing on nanofiber scaffolds.Limbal Stem Cell Deficiency and Treatment with Stem Cell Transplantation.Mesenchymal stem cells, nanofiber scaffolds and ocular surface reconstruction.Limbal Stem Cell Transplantation and Complications.Towards a richer debate on tissue engineering: a consideration on the basis of NEST-ethics.Electrospun mat with eyelid fat-derived stem cells as a scaffold for ocular epithelial regeneration.Mounting of Biomaterials for Use in Ophthalmic Cell Therapies.Successful Consecutive Expansion of Limbal Explants Using a Biosafe Culture Medium under Feeder Layer-Free Conditions.Effect of Storage Temperature on the Phenotype of Cultured Epidermal Cells Stored in Xenobiotic-Free Medium.Oriented nanofibrous silk as a natural scaffold for ocular epithelial regeneration.Human corneal endothelial cell transplantation using nanocomposite gel sheet in bullous keratopathy.Loss of corneal epithelial stem cell properties in outgrowths from human limbal explants cultured on intact amniotic membrane.Cellular Response of Limbal Stem Cells on Polycaprolactone Nanofibrous Scaffolds for Ocular Epithelial Regeneration.Drug loading and delivery using nanofibers scaffolds.
P2860
Q33478432-1B06CEBD-6278-4363-AB50-8FF2F194C9A4Q35143610-769AD003-2012-423F-8A69-68CBF74FF4CEQ35556466-3D5B8496-930E-4F31-9E25-9BCEA14280CFQ35575086-1593D3C8-9A8E-4D3C-BF5B-CC956A3B0222Q36651208-B0C5CA97-095B-4258-850B-307EF32956C6Q37409312-576B2968-B512-4F59-856A-290068A4753CQ37509181-A547FB7D-100A-4C3D-9C98-69B43DC4A450Q37838845-78A7B53C-0365-41D7-9AAF-41BD51CD5058Q38041572-4D83EC23-CC7F-4F69-8132-9443DE83F4E2Q38201458-B87865E1-FD43-45F0-8C0B-79378AC8667AQ38515488-4E9403E4-83D2-44D1-8E1E-50413B9F329BQ38687810-83062A31-D4C7-446F-9E64-D0AEE037A394Q38833691-C333B49E-070D-4E9C-8B30-748431BE5B43Q39242600-C680D985-CE97-4B10-A90B-DAA386AE6438Q39279363-0B9C4BD1-4877-44F6-810F-C047EF975AD3Q41060712-8D4A721E-682D-4BE4-AE27-A6B5216CCE61Q41125630-DAB7174A-36BF-4BFB-840A-9354511D3B49Q41850284-F64D7ACD-82CC-4F33-A898-8B27E2A14CC2Q41959185-1DEC7044-7DF7-4DB3-BEBC-C56976DE3A0DQ42795772-C19272BF-BFA7-49FE-ADBE-2EE102C5EF0EQ43007568-EDDB385E-353C-4DC0-B44B-616DFFFA5EFBQ43448283-F9BFDE89-BB37-44D1-A2EC-C358085D6127Q47629808-E47D6FAB-6450-4165-B96E-119CAC79973CQ48238142-5F81EC1C-AF37-455D-9170-0460CC8BFED5Q48338975-632F76C1-4CA8-4373-AFBD-BEB34A2AFC40Q48932569-EE251B31-52D8-459A-BD83-3FACA967EAACQ49414937-B8A24F09-8CC6-424A-AA17-C72E2B4127DCQ51031200-B5DFDD51-F041-4F61-B9AD-4C51CE5119F8Q51710299-515E02B6-2CE4-4FF3-B81A-14B97324B888Q51789383-67282CC1-5946-48A1-B6A2-412D14F8AF4AQ52726986-07DD28DC-CFBF-44F3-A174-670CB0D2B417Q53478922-2B04E96B-B4D8-4E21-A637-A857CDED54CBQ53533280-976FEAC2-DA10-4DCD-BAF2-B932C4F88B12Q54627044-2E73ABB7-43AE-435C-A7A4-7F12FE3EA1D8
P2860
Inherent risks associated with manufacture of bioengineered ocular surface tissue.
description
2006 nî lūn-bûn
@nan
2006 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Inherent risks associated with manufacture of bioengineered ocular surface tissue.
@ast
Inherent risks associated with manufacture of bioengineered ocular surface tissue.
@en
Inherent risks associated with manufacture of bioengineered ocular surface tissue.
@nl
type
label
Inherent risks associated with manufacture of bioengineered ocular surface tissue.
@ast
Inherent risks associated with manufacture of bioengineered ocular surface tissue.
@en
Inherent risks associated with manufacture of bioengineered ocular surface tissue.
@nl
prefLabel
Inherent risks associated with manufacture of bioengineered ocular surface tissue.
@ast
Inherent risks associated with manufacture of bioengineered ocular surface tissue.
@en
Inherent risks associated with manufacture of bioengineered ocular surface tissue.
@nl
P2093
P1433
P1476
Inherent risks associated with manufacture of bioengineered ocular surface tissue.
@en
P2093
Damien G Harkin
Ivan R Schwab
Nigel T Johnson
P304
P356
10.1001/ARCHOPHT.124.12.1734
P407
P577
2006-12-01T00:00:00Z